GAROFALO HEALTH CARE SPA (GHC.MI) Fundamental Analysis & Valuation

BIT:GHC • IT0005345233

Current stock price

5.27 EUR
+0.08 (+1.54%)
Last:

This GHC.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. GHC.MI Profitability Analysis

1.1 Basic Checks

  • GHC had positive earnings in the past year.
  • GHC had a positive operating cash flow in the past year.
  • GHC had positive earnings in each of the past 5 years.
  • In the past 5 years GHC always reported a positive cash flow from operatings.
GHC.MI Yearly Net Income VS EBIT VS OCF VS FCFGHC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • The Return On Assets of GHC (3.66%) is better than 72.73% of its industry peers.
  • With a Return On Equity value of 9.57%, GHC perfoms like the industry average, outperforming 57.58% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 6.52%, GHC is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for GHC is in line with the industry average of 6.06%.
  • The 3 year average ROIC (4.41%) for GHC is below the current ROIC(6.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.66%
ROE 9.57%
ROIC 6.52%
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
GHC.MI Yearly ROA, ROE, ROICGHC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 4.62%, GHC is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • In the last couple of years the Profit Margin of GHC has declined.
  • GHC's Operating Margin of 9.37% is fine compared to the rest of the industry. GHC outperforms 78.79% of its industry peers.
  • GHC's Operating Margin has declined in the last couple of years.
  • The Gross Margin of GHC (44.90%) is better than 66.67% of its industry peers.
  • In the last couple of years the Gross Margin of GHC has remained more or less at the same level.
Industry RankSector Rank
OM 9.37%
PM (TTM) 4.62%
GM 44.9%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
GHC.MI Yearly Profit, Operating, Gross MarginsGHC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. GHC.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GHC is still creating some value.
  • Compared to 1 year ago, GHC has about the same amount of shares outstanding.
  • The number of shares outstanding for GHC has been increased compared to 5 years ago.
  • Compared to 1 year ago, GHC has an improved debt to assets ratio.
GHC.MI Yearly Shares OutstandingGHC.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
GHC.MI Yearly Total Debt VS Total AssetsGHC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 1.93 indicates that GHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • GHC has a Altman-Z score of 1.93. This is comparable to the rest of the industry: GHC outperforms 51.52% of its industry peers.
  • GHC has a debt to FCF ratio of 70.49. This is a negative value and a sign of low solvency as GHC would need 70.49 years to pay back of all of its debts.
  • GHC has a worse Debt to FCF ratio (70.49) than 72.73% of its industry peers.
  • A Debt/Equity ratio of 0.67 indicates that GHC is somewhat dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.67, GHC is doing good in the industry, outperforming 75.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 70.49
Altman-Z 1.93
ROIC/WACC1
WACC6.49%
GHC.MI Yearly LT Debt VS Equity VS FCFGHC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

  • GHC has a Current Ratio of 1.16. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
  • GHC has a better Current ratio (1.16) than 60.61% of its industry peers.
  • GHC has a Quick Ratio of 1.12. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
  • GHC's Quick ratio of 1.12 is fine compared to the rest of the industry. GHC outperforms 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.12
GHC.MI Yearly Current Assets VS Current LiabilitesGHC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. GHC.MI Growth Analysis

3.1 Past

  • GHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.11%.
  • GHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.81% yearly.
  • Looking at the last year, GHC shows a quite strong growth in Revenue. The Revenue has grown by 10.44% in the last year.
  • Measured over the past years, GHC shows a quite strong growth in Revenue. The Revenue has been growing by 18.92% on average per year.
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.47% on average over the next years.
  • The Revenue is expected to grow by 1.51% on average over the next years.
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GHC.MI Yearly Revenue VS EstimatesGHC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
GHC.MI Yearly EPS VS EstimatesGHC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

3

4. GHC.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.64, the valuation of GHC can be described as correct.
  • 69.70% of the companies in the same industry are more expensive than GHC, based on the Price/Earnings ratio.
  • GHC is valuated rather cheaply when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • GHC is valuated correctly with a Price/Forward Earnings ratio of 16.31.
  • Based on the Price/Forward Earnings ratio, GHC is valued a bit more expensive than 63.64% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. GHC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.64
Fwd PE 16.31
GHC.MI Price Earnings VS Forward Price EarningsGHC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GHC is valued a bit cheaper than the industry average as 78.79% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GHC indicates a slightly more expensive valuation: GHC is more expensive than 72.73% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 146.35
EV/EBITDA 7.22
GHC.MI Per share dataGHC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of GHC may justify a higher PE ratio.
PEG (NY)4.25
PEG (5Y)1.66
EPS Next 2Y5.05%
EPS Next 3Y6.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. GHC.MI Dividend Analysis

5.1 Amount

  • GHC has a Yearly Dividend Yield of 1.62%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.61, GHC has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, GHC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.62%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y5.05%
EPS Next 3Y6.47%
GHC.MI Yearly Income VS Free CF VS DividendGHC.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

GHC.MI Fundamentals: All Metrics, Ratios and Statistics

GAROFALO HEALTH CARE SPA

BIT:GHC (3/13/2026, 5:06:51 PM)

5.27

+0.08 (+1.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14
Earnings (Next)N/A
Inst Owners10.79%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap475.35M
Revenue(TTM)690.85M
Net Income(TTM)31.91M
Analysts84
Price Target6.73 (27.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.62%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.64
Fwd PE 16.31
P/S 0.69
P/FCF 146.35
P/OCF 17.02
P/B 1.43
P/tB N/A
EV/EBITDA 7.22
EPS(TTM)0.36
EY6.83%
EPS(NY)0.32
Fwd EY6.13%
FCF(TTM)0.04
FCFY0.68%
OCF(TTM)0.31
OCFY5.88%
SpS7.66
BVpS3.7
TBVpS-0.44
PEG (NY)4.25
PEG (5Y)1.66
Graham Number5.47
Profitability
Industry RankSector Rank
ROA 3.66%
ROE 9.57%
ROCE 9.13%
ROIC 6.52%
ROICexc 6.77%
ROICexgc 14.86%
OM 9.37%
PM (TTM) 4.62%
GM 44.9%
FCFM 0.47%
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
ROICexc(3y)4.63%
ROICexc(5y)4.13%
ROICexgc(3y)10.78%
ROICexgc(5y)9.37%
ROCE(3y)6.5%
ROCE(5y)5.8%
ROICexgc growth 3Y7.97%
ROICexgc growth 5Y2.8%
ROICexc growth 3Y6.71%
ROICexc growth 5Y0.74%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 70.49
Debt/EBITDA 2.47
Cap/Depr 94.13%
Cap/Sales 3.57%
Interest Coverage 6.62
Cash Conversion 30.7%
Profit Quality 10.18%
Current Ratio 1.16
Quick Ratio 1.12
Altman-Z 1.93
F-Score5
WACC6.49%
ROIC/WACC1
Cap/Depr(3y)82.25%
Cap/Depr(5y)102.09%
Cap/Sales(3y)4.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)118.21%
Profit Quality(5y)101.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
EBIT growth 1Y-8.88%
EBIT growth 3Y18.26%
EBIT growth 5Y14.91%
EBIT Next Year68.09%
EBIT Next 3Y22.98%
EBIT Next 5Y16.09%
FCF growth 1Y-88.34%
FCF growth 3Y4.79%
FCF growth 5Y6.69%
OCF growth 1Y-35.2%
OCF growth 3Y-1.23%
OCF growth 5Y13.09%

GAROFALO HEALTH CARE SPA / GHC.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GAROFALO HEALTH CARE SPA (GHC.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to GHC.MI.


What is the valuation status for GHC stock?

ChartMill assigns a valuation rating of 3 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Overvalued.


How profitable is GAROFALO HEALTH CARE SPA (GHC.MI) stock?

GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 6 / 10.


What is the financial health of GAROFALO HEALTH CARE SPA (GHC.MI) stock?

The financial health rating of GAROFALO HEALTH CARE SPA (GHC.MI) is 4 / 10.


What is the expected EPS growth for GAROFALO HEALTH CARE SPA (GHC.MI) stock?

The Earnings per Share (EPS) of GAROFALO HEALTH CARE SPA (GHC.MI) is expected to grow by 3.45% in the next year.